Thomas W. Apel

1.6k total citations
9 papers, 197 citations indexed

About

Thomas W. Apel is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Thomas W. Apel has authored 9 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Thomas W. Apel's work include Cancer, Hypoxia, and Metabolism (4 papers), Adenosine and Purinergic Signaling (3 papers) and Adrenal and Paraganglionic Tumors (3 papers). Thomas W. Apel is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Adenosine and Purinergic Signaling (3 papers) and Adrenal and Paraganglionic Tumors (3 papers). Thomas W. Apel collaborates with scholars based in Germany, Switzerland and Netherlands. Thomas W. Apel's co-authors include Hartmut P.H. Neumann, E. Natt, Sven Gläsker, R. Scheremet, B Bender, Vera Van Velthoven, Josef Zentner, Oliver Vonend, Eberhard Ritz and Lars Christian Rump and has published in prestigious journals such as Kidney International, Journal of Neurology Neurosurgery & Psychiatry and Gene.

In The Last Decade

Thomas W. Apel

9 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas W. Apel Germany 7 85 58 50 32 28 9 197
Lasse Bach Steffensen Denmark 11 45 0.5× 100 1.7× 55 1.1× 13 0.4× 45 1.6× 25 271
Oskar Aspegren Sweden 5 28 0.3× 88 1.5× 56 1.1× 95 3.0× 7 0.3× 9 319
Morgane Pertuit France 10 68 0.8× 89 1.5× 76 1.5× 39 1.2× 104 3.7× 16 247
Jiaoxing Li China 10 28 0.3× 61 1.1× 41 0.8× 135 4.2× 28 1.0× 30 301
Jen‐Yea Chang United States 9 26 0.3× 73 1.3× 26 0.5× 7 0.2× 10 0.4× 9 331
L. J. McCormack United Kingdom 8 82 1.0× 36 0.6× 35 0.7× 50 1.6× 48 1.7× 11 253
Andrea Pace Germany 9 26 0.3× 107 1.8× 105 2.1× 239 7.5× 46 1.6× 12 530
Xiaohai Zhou China 10 98 1.2× 237 4.1× 22 0.4× 7 0.2× 16 0.6× 17 348
Daniela Cordella Italy 8 34 0.4× 178 3.1× 41 0.8× 10 0.3× 183 6.5× 9 367

Countries citing papers authored by Thomas W. Apel

Since Specialization
Citations

This map shows the geographic impact of Thomas W. Apel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas W. Apel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas W. Apel more than expected).

Fields of papers citing papers by Thomas W. Apel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas W. Apel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas W. Apel. The network helps show where Thomas W. Apel may publish in the future.

Co-authorship network of co-authors of Thomas W. Apel

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas W. Apel. A scholar is included among the top collaborators of Thomas W. Apel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas W. Apel. Thomas W. Apel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Vonend, Oliver, Thomas W. Apel, Kerstin Amann, et al.. (2004). Modulation of gene expression by moxonidine in rats with chronic renal failure. Nephrology Dialysis Transplantation. 19(9). 2217–2222. 18 indexed citations
2.
Vonend, Oliver, Vitus Oberhauser, Ivar von Kügelgen, et al.. (2002). ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells. Kidney International. 61(5). 1617–1626. 41 indexed citations
3.
Reichardt, Peter, Thomas W. Apel, Ralf‐Bodo Tröbs, et al.. (2002). Recurrent Polytopic Chromaffin Paragangliomas in a 9-Year-Old Boy Resulting From a Novel Germline Mutation in the von Hippel–Lindau Gene. ˜The œAmerican journal of pediatric hematology/oncology. 24(2). 145–148. 7 indexed citations
4.
Apel, Thomas W., et al.. (2001). Phaeochromocytoma associated with a de novo VHL mutation as form fruste of von Hippel-Lindau disease. European Journal of Pediatrics. 160(7). 421–424. 6 indexed citations
5.
Januszewicz, Andrzej, Hartmut P.H. Neumann, Cezary Szmigielski, et al.. (2000). Incidence and clinical relevance of RET proto-oncogene germline mutations in pheochromocytoma patients. Journal of Hypertension. 18(8). 1019–1023. 12 indexed citations
6.
Roijers, Janine, Thomas W. Apel, Hartmut P.H. Neumann, et al.. (2000). Internally shortened menin protein as a consequence of alternative RNA splicing due to a germline deletion in the multiple endocrine neoplasia type 1 gene.. International Journal of Molecular Medicine. 5(6). 611–4. 2 indexed citations
7.
Gläsker, Sven, B Bender, Thomas W. Apel, et al.. (1999). The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. Journal of Neurology Neurosurgery & Psychiatry. 67(6). 758–762. 77 indexed citations
8.
9.
Apel, Thomas W., Josef Mautner, Axel Polack, Georg W. Bornkamm, & Dirk Eick. (1992). Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.. PubMed. 7(7). 1267–71. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026